Pulse Biosciences (PLSE) Retained Earnings (2015 - 2025)
Pulse Biosciences (PLSE) recorded quarterly Retained Earnings of -$463.3 million in Q4 2025, down 3.91% quarter-over-quarter from -$445.8 million in Q3 2025, and down 18.64% on a YoY basis from -$569.5 million in Q4 2024.
Pulse Biosciences (PLSE) Retained Earnings (2015 - 2025) Analysis & Trends
Pulse Biosciences' Retained Earnings history runs 11 years deep, the most recent figure standing at -$463.3 million for Q4 2025.
- In Q4 2025, Retained Earnings fell 18.64% year-over-year to -$463.3 million; the TTM figure through Dec 2025 stood at -$463.3 million (down 18.64% YoY), while the FY2025 annual figure was -$463.3 million, down 18.64% from the prior year.
- Retained Earnings was -$463.3 million for Q4 2025 at Pulse Biosciences, down from -$445.8 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$191.2 million in Q1 2021 to a low of -$463.3 million in Q4 2025.
- Historically, Retained Earnings has averaged -$319.7 million across 5 years, with a median of -$320.7 million in 2021.
- The sharpest annual moves came in 2021 and 2024: Retained Earnings slumped 33691400.0% in 2021, then dropped 13.97% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$336.9 million in 2021, then rose by 15.26% to -$285.5 million in 2022, then decreased by 18.01% to -$336.9 million in 2023, then decreased by 15.9% to -$390.5 million in 2024, then decreased by 18.64% to -$463.3 million in 2025.
- The last three Retained Earnings figures came in at -$463.3 million (Q4 2025), -$445.8 million (Q3 2025), and -$426.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 6.40 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 17.39 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 122.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 6.96 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 4.48 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -670.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 7.70 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 70.09 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 13.69 Bn |
| 10 | Pulse Biosciences | 1.68 Bn | 1.68 Bn | - | -463.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -463.30 Mn |
| Sep 30, 2025 | -445.85 Mn |
| Jun 30, 2025 | -426.46 Mn |
| Dec 31, 2024 | -390.50 Mn |
| Mar 31, 2024 | -347.05 Mn |
| Dec 31, 2023 | -336.92 Mn |
| Mar 31, 2023 | -304.51 Mn |
| Sep 30, 2022 | -285.51 Mn |
| Jun 30, 2022 | -267.50 Mn |
| Mar 31, 2022 | -253.47 Mn |
| Dec 31, 2021 | -336.92 Mn |
| Sep 30, 2021 | -220.80 Mn |
| Jun 30, 2021 | -206.50 Mn |
| Mar 31, 2021 | -191.18 Mn |
| Dec 31, 2020 | -1,000.00 |
| Sep 30, 2020 | -158.80 Mn |
| Jun 30, 2020 | -145.89 Mn |
| Mar 31, 2020 | 17,000.00 |
| Dec 31, 2019 | -122.69 Mn |
| Sep 30, 2019 | -108.90 Mn |